Abmgood Sv40 Lentivirus

Lenti-SV40 Lentivirus

G203 10 ml
EUR 973.2

Abmgood Laboratories manufactures the abmgood sv40 lentivirus reagents distributed by Genprice. The Abmgood Sv40 Lentivirus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ABMgood. Other Abmgood products are available in stock. Specificity: Abmgood Category: Sv40 Group: Lentivirus

Lenti-SV40 (tsA58 temperature sensitive mutant) Lentivirus, High Titer

5 x 20 ul
EUR 725
Description: High Titer Lentivirus expressing SV40 large T tsA58 antigen (10⁹IU/ml)

Sv40 Large T-antigen (CMV, Hygro) Lentivirus in PBS

1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated Lentivirus expresses SV40 large T-antigen under suCMV promoter, containing Hygromycin selection.

Sv40 Large T-antigen (CMV, Zeo) Lentivirus in PBS

1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated Lentivirus expresses SV40 large T-antigen under suCMV promoter, containing Zeocin selection.

Sv40 Large T-antigen (EF1a, Hygro) Lentivirus in PBS

1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated Lentivirus expresses SV40 large T-antigen under EF1a promoter, containing Hygromycin selection.

Sv40 Large T-antigen (EF1a, Zeo) Lentivirus in PBS

1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated Lentivirus expresses SV40 large T-antigen under EF1a promoter, containing Zeocin selection.

True Blue

5.0mg
EUR 595

True Blue

10mg Ask for price
Description: True Blue

Lentivirus information

CD8a Lentivirus

78648 500 µl x 2
EUR 995
Description: CD8 (cluster of differentiation 8) is a cell surface glycoprotein found on most cytotoxic T lymphocytes that functions within the immune system to mediate cell-cell interactions. The functional forms of CD8 consist of either a heterodimer of two isoforms, CD8α and CD8β, or a homodimer of two CD8α molecules. CD8 acts as a coreceptor to facilitate binding between the T-cell Receptor (TCR) and the class I Major Histocompatibility Complex (MHC).  Studying CD8 and its importance in isoimmunity can further our understanding of post-transplant recognition.The CD8a (CD8α, CD8 alpha) Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human CD8a (NM_001768.6) driven by an EF1a promoter and a puromycin selection marker.)

CD19 Lentivirus

78657 500 µl x 2
EUR 995
Description: The CD19 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD19 (NM_001770) under the control of an EF1a promoter.

CD20 Lentivirus

78658 500 µl x 2
EUR 995
Description: The CD20 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD20 (NM_021950) under the control of an EF1a promot/ .

CD22 Lentivirus

78659 500 µl x 2
EUR 995
Description: The CD22 Lentiviruses are replication incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express human CD22 (NM_001771) under the control of an EF1a promoter.

GPC3 Lentivirus

78711 500 µl x 2
EUR 835
Description: The GPC3 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human GPC3 (Glypican 3, NM_ 004484.2) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_

_x000D_Figure 1: Schematic of the lenti-vector used to generate the GPC3 Lentivirus.

BCMA Lentivirus

78714 500 µl x 2
EUR 795
Description: The BCMA Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human BCMA (NM_ 001192) driven by a CMV promoter and a G418 selection marker (Figure 1)._x000D__x000D_Figure 1: Schematic of the lenti-vector used to generate the BCMA Lentivirus

PSMA Lentivirus

78726 500 µl x 2
EUR 995
Description: The PSMA Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human PSMA (NM_ 004476.3) driven by a CMV promoter and a puromycin selection marker (Figure 1)._x000D_

_x000D_Figure 1: Schematic of the lenti-vector used to generate the PSMA Lentivirus.

Trop2 Lentivirus

78710 500 µl x 2
EUR 795
Description: The Trop2 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human Trop2 (NM_002353.2) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_ _x000D_Figure 1: Schematic of the lenti-vector used to generate the Trop2 Lentivirus

FcRL5 Lentivirus

78715 500 µl x 2
EUR 1005
Description: The FcRL5 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human FcRL5 (NM_031281.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D__x000D_Figure 1: Schematic of the lenti-vector used to generate the FcRL5 Lentivirus.

NKp46 Lentivirus

78717 500 µl x 2
EUR 795
Description: The NKp46 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human NKp46 (NM_004829.7) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D__x000D_Figure 1: Schematic of the lenti-vector used to generate the NKp46 Lentivirus.

EpCAM Lentivirus

78718 500 µl x 2
EUR 995
Description: The EpCAM Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human EpCAM (NM_002354.3) driven by an EF1A promoter and a puromycin selection marker (Figure 1)._x000D_

_x000D_Figure 1: Schematic of the lenti-vector used to generate the EpCAM Lentivirus

LYPD1 Lentivirus

78724 500 µl x 2
EUR 795
Description: The LYPD1 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human LYPD1 (NM_ 001321234.2) driven by a EF1A promoter and a puromycin selection marker (Figure 1)._x000D__x000D_Figure 1: Schematic of the lenti-vector used to generate the LYPD1 Lentivirus

EF1a-(Red-Luciferase) Lentivirus (Zeocin), Concentrated Lentivirus

LVP1304-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Zeocin selection.

FcER1G Lentivirus

79878 500 µl x 2
EUR 795
Description: FcER1G is an adapter protein containing an immunoreceptor tyrosine-based activation motif (ITAM) that transduces activation signals from various immunoreceptors. As a component of the high-affinity immunoglobulin E (IgE) receptor, FcER1G mediates allergic inflammatory signaling in mast cells. FcER1G is also a subunit of other Fc receptors.
The FcER1G Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. The particles contain a FcER1G gene (NM_004106.2) driven by an EF1α promoter._x000D_

GPRC5D Lentivirus

78716 500 µl x 2
EUR 795
Description: The GPRC5D Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. The particles contain a human GPRC5D (NM_018654.1) driven by a CMV promoter and a Hygromycin selection marker (Figure 1)._x000D__x000D_Figure 1: Schematic of the lenti-vector used to generate the GPRC5D Lentivirus

EF1a-(Red-Luciferase) Lentivirus (Neomycin), Concentrated Lentivirus

LVP1234-PBS 1x10^8 IFU/ml x 200ul
EUR 455
Description: concentrated lentivirus in PBS express Red-Luciferease under EF1a promoter, containing Neomycin selection.

TMPRSS2 Lentivirus

78011-1 100 µl
EUR 795
Description: Human transmembrane serine protease 2 (TMPRSS2) is an enzyme primarily expressed by endothelial cells across the respiratory and digestive tracts. It is involved in viral entry and spread of coronaviruses including SARS-CoV-2, the virus that causes COVID19. TMPRSS2 primes the spike protein by cleaving at the S1/S2 site, leading to the virus fusing to the respiratory epithelia on the cell surface through binding to ACE2. Blocking TMPRSS2 activity could potentially be an effective clinical therapy for COVID-19._x000D_
The TMPRSS2 Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an TMPRSS2 gene (NM_005656.4) driven by an EF1a promoter._x000D_